Next Article in Journal / Special Issue
Effect of Milk Fermented with Lactobacillus fermentum on the Inflammatory Response in Mice
Previous Article in Journal
Erratum: Cost-Effectiveness of Product Reformulation in Response to the Health Star Rating Food Labelling System in Australia; Nutrients 2018, 10, 614
Previous Article in Special Issue
Zinc and Sepsis

Human Milk Oligosaccharides and Immune System Development

by 1,2,3, 1,2,3 and 1,2,3,4,*
Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, 18071 Granada, Spain
Institute of Nutrition and Food Technology “José Mataix”, Biomedical Research Center, Parque Tecnológico Ciencias de la Salud, University of Granada, Armilla, 18100 Granada, Spain
Instituto de Investigación Biosanitaria ibs., 18014 Granada, Spain
CIBEROBN, Instituto de Salud Carlos III, 28029 Madrid, Spain
Author to whom correspondence should be addressed.
Nutrients 2018, 10(8), 1038;
Received: 19 July 2018 / Revised: 1 August 2018 / Accepted: 6 August 2018 / Published: 8 August 2018
(This article belongs to the Special Issue Diet and Immune Function)
Maternal milk contains compounds that may affect newborn immunity. Among these are a group of oligosaccharides that are synthesized in the mammary gland from lactose; these oligosaccharides have been termed human milk oligosaccharides (HMOs). The amount of HMOs present in human milk is greater than the amount of protein. In fact, HMOs are the third-most abundant solid component in maternal milk after lactose and lipids, and are thus considered to be key components. The importance of HMOs may be explained by their inhibitory effects on the adhesion of microorganisms to the intestinal mucosa, the growth of pathogens through the production of bacteriocins and organic acids, and the expression of genes that are involved in inflammation. This review begins with short descriptions of the basic structures of HMOs and the gut immune system, continues with the beneficial effects of HMOs shown in cell and animal studies, and it ends with the observational and randomized controlled trials carried out in humans to date, with particular emphasis on their effect on immune system development. HMOs seem to protect breastfed infants against microbial infections. The protective effect has been found to be exerted through cell signaling and cell-to-cell recognition events, enrichment of the protective gut microbiota, the modulation of microbial adhesion, and the invasion of the infant intestinal mucosa. In addition, infants fed formula supplemented with selected HMOs exhibit a pattern of inflammatory cytokines closer to that of exclusively breastfed infants. Unfortunately, the positive effects found in preclinical studies have not been substantiated in the few randomized, double-blinded, multicenter, controlled trials that are available, perhaps partly because these studies focus on aspects other than the immune response (e.g., growth, tolerance, and stool microbiota). View Full-Text
Keywords: human milk oligosaccharides; intestinal immune system; microbiota human milk oligosaccharides; intestinal immune system; microbiota
Show Figures

Figure 1

MDPI and ACS Style

Plaza-Díaz, J.; Fontana, L.; Gil, A. Human Milk Oligosaccharides and Immune System Development. Nutrients 2018, 10, 1038.

AMA Style

Plaza-Díaz J, Fontana L, Gil A. Human Milk Oligosaccharides and Immune System Development. Nutrients. 2018; 10(8):1038.

Chicago/Turabian Style

Plaza-Díaz, Julio, Luis Fontana, and Angel Gil. 2018. "Human Milk Oligosaccharides and Immune System Development" Nutrients 10, no. 8: 1038.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop